Table 3. Lesional characteristics.
| Overall population | Alb <4.0 g/dL | Alb ≥4.0 g/dL | p-value | |
|---|---|---|---|---|
| (n = 204) | (n = 89) | (n = 115) | ||
| Multivessel disease (%) | 53 (26) | 26 (29) | 27 (24) | 0.354 |
| LMT lesions (%) | 13 (6) | 8 (9) | 5 (4) | 0.178 |
| Calcified lesions (%) | 29 (14) | 20 (23) | 9 (8) | 0.003 |
| Ostial lesions (%) | 30 (15) | 15 (17) | 15 (13) | 0.446 |
| Bifurcation lesions (%) | 102 (50) | 45 (51) | 57 (50) | 0.888 |
| CTO lesions (%) | 12 (6) | 3 (3) | 9 (8) | 0.18 |
| DES use (%) | 193 (95) | 83 (93) | 110 (96) | 0.453 |
| BMS use (%) | 11 (5) | 6 (7) | 5 (4) | 0.453 |
Values are presented as median [interquartile range], or n (%). Abbreviations: Alb = serum albumin; BMS = bare metal stent; CTO = chronic total occlusion; DES = drug-eluting stent; LMT = left main trunk.